Home \ Neurology \ Traumatic Brain Injury in Clinical Practice

Cranial injury in clinical practice

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
General approaches to a patient with a traumatic brain injury
02:32
Severity on the scale of the Coma Glasgow and postcommunication syndrome
04:06
Complications and consequences of traumatic brain injury
05:15
Research methods in the acute period
07:25
Neurocytoprotectors and their effectiveness
11:27
Recommendations for the use of Mexidol® in the acute period
13:10
Recommendations for pharmacotherapy after an acute period
15:50
The feasibility of repeated therapy courses in patients with traumatic brain injury
16:17
Clinical advantages of consistent therapy

Evgeniya Viktorovna Yekusheva – Doctor of Medical Sciences, Professor, Head of the Department of Nervous System Diseases and Neurorehabilitation of the Academy of Postgraduate Education of the Federal Scientific and Clinical Center of the Federal Medical and Biological Agency of Russia

Pavel Rudolfovich Kamchatnov , Doctor of Medical Sciences, Professor of the Department of Neurology, Neurosurgery, and Medical Genetics of the Faculty of Medicine at the N.I. Pirogov Russian National Research Medical University

Announcement:

Traumatic brain injury (TBI) cannot be prevented. However, its incidence remains very high. Post-concussion syndrome is a common complication following TBI. These patients most often complain of decreased concentration and memory impairment. The use of neurocytoprotectors, one of the most promising classes of medications for the treatment of neurological diseases, allows for the effective management of patients with TBI. in patients with TBI reduces oxidative stress and promotes the normalization of brain metabolism

All videos Next video

The brain in focus of arterial hypertension

Peculiarities of managing elderly patients

The brain is a key target organ for treatment of cerebrovascular risks

Mexidol as a geroprotector: potential and prospects

Neuroprotection in arterial hypertension and cognitive impairment

The Connection Between Vascular Diseases of the Brain and Eye: A Neurologist and Ophthalmologist's Perspective

Ischemic stroke: clinical guidelines and practical aspects

NIHSS and mRS: Gold Standards in Neuroscience

Cognitive impairment caused by arterial hypertension: from clinical guidelines to practical algorithms

The brain is a target organ for arterial hypertension: features of management of the elderly patient

Time codes:

00:00
General approaches to a patient with a traumatic brain injury
02:32
Severity on the scale of the Coma Glasgow and postcommunication syndrome
04:06
Complications and consequences of traumatic brain injury
05:15
Research methods in the acute period
07:25
Neurocytoprotectors and their effectiveness
11:27
Recommendations for the use of Mexidol® in the acute period
13:10
Recommendations for pharmacotherapy after an acute period
15:50
The feasibility of repeated therapy courses in patients with traumatic brain injury
16:17
Clinical advantages of consistent therapy

Block of articles on this topic

Features of patients with traumatic brain injury

Authors:
M.L. CHUKHLOVINA¹, A.A. CHUKHLOVIN²

¹Almazov National Medical Research Center of the Russian Ministry of Health, Saint Petersburg, Russia;
²Russian Neurosurgical Research Institute named after prof. A.L. Polenov — branch of the Almazov National Medical Research Center of the Russian Ministry of Health, Saint Petersburg, Russia

Oxidative stress and its drug correction by Mexidol with traumatic brain injury

Author:
N.V. GOVOROVA

State Budgetary Educational Institution of Higher Professional Education "Omsk State Medical Academy of the Ministry of Health", Omsk, Russia

The effectiveness of the drug "Mexidol" in patients with a combined traumatic brain injury

Authors:
I.B. SAVITSKAYA, V.V. NIKONOV, A.V. CHERNOV, A.Yu. PAVLENKO, A.V. BELETSKY

Kharkov Medical Academy of Postgraduate Education, Kharkov City Clinical Hospital of Emergency and Emergency Medical Assistance

Mexidol in the prevention of intracranial hypertension syndrome with the consequences of closed traumatic brain injury

Authors:
B.M. DORONIN, A.YU. LETYAGIN, O.B. TYSHKEVICH, V.B. DORONIN

Novosibirsk State Medical University, Novosibirsk, 2006

Clinical assessment of the drug Mexol in the treatment of severe traumatic brain injury at the stages of medical care

Author:
V.L. RADUSHKEVICH

Voronezh State Medical Academy. N. N. Burdenko, Voronezh

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com